Anti-obesity drugs.
Proietto
J
J
University of Melbourne, Department of Medicine, Royal Melbourne Hospital, VIC. j.proietto@medicine.unimelb.edu.au
D000322:Adrenergic Agonists / Q000494:pharmacology; D019440:Anti-Obesity Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001067:Appetite Depressants / Q000494:pharmacology; D003503:Cyclobutanes / Q000494:pharmacology; D006801:Humans; D007783:Lactones / Q000494:pharmacology; D008049:Lipase / Q000037:antagonists & inhibitors; D009765:Obesity / Q000188:drug therapy; D000077403:Orlistat; D017366:Serotonin Receptor Agonists / Q000494:pharmacology; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology
D000322:Adrenergic Agonists; D019440:Anti-Obesity Agents; D001067:Appetite Depressants; D003503:Cyclobutanes; D007783:Lactones; D008049:Lipase; D000077403:Orlistat; D017366:Serotonin Receptor Agonists; D017367:Selective Serotonin Reuptake Inhibitors; C058254:sibutramine